Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation

Blood

Volumn 94, Issue 3, 1999, Pages 1131-1136

  Storb, Rainer ^a   Yu, Cong ^b   Barnett, Todd ^b   Wagner, John L ^b   Deeg, H Joachim ^b   Nash, Richard A ^b   Kiem, Hans Peter ^b   McSweeney, Peter ^b   Seidel, Kristy ^b   Georges, George ^b   Zaucha, J Maciej ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DOG; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOCRIT; HEMATOPOIESIS; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE IRRADIATION; LYMPHOCYTE COUNT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

EID: 0033178876     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.1131.415k21_1131_1136     Document Type: Article

References (32)

1. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89:3048, 1997
2. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA: Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62:876, 1996
3. Wagner JL, Burnett RC, Works JD, Storb R: Molecular analysis of DLA-DRBB1 polymorphism. Tissue Antigens 48:554, 1996
4. Ladiges WC, Storb R, Graham T, Thomas ED: Experimental techniques used to study the immune system of dogs and other large animals, in Gay WI, Heavener JE (eds): Methods of Animal Experimentation, New York, NY, Academic, 1989, p 103
5. Ladiges WC, Storb R, Thomas ED: Canine models of bone marrow transplantation. Lab Anim Sci 40:11, 1990
6. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58:701, 1994
7. 32P-postlabeling assay. Carcinogenesis 13: 1475, 1992
8. Sandmaier BM, Schuening FG, Bianco JA, Rosenman SJ, Bernstein I, Goehle S, Storb R, Appelbaum FR: Biochemical characterization of a unique canine myeloid antigen. Leukemia 5:125, 1991
9. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Severns E: Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high density expression of CD4 by canine neutrophils. Tissue Antigens 40:75, 1992
10. Georges G, Storb R, Yu C, Torok-Storb B, Thompson J, Bruno B, Nash R: Conversion from mixed to all donor chimerism following infusion of minor histocompatibility antigen-specific donor lymphocytes in dogs. Blood 92:435a, 1998 (suppl 1, abstr)
11. Storb R, Yu C, McSweeney P: Mixed chimerism after transplantation of allogeneic hematopoietic cells, in Thomas ED, Blume KG, Forman SJ (eds): Hematopoietic Cell Transplantation, ed 2. Boston, MA, Blackwell Science, 1999, p 287
12. Cobbold SP, Martin G, Qin S, Waldmann H: Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323:164, 1986
13. Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST: Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 156:380, 1996
14. Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST: Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 157:2820, 1996
15. Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST: A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 155: 4179, 1995
16. Sharabi Y, Abraham VS, Sykes M, Sachs DH: Mixed allogeneic chimeras prepared by a non-myeloablative regimen: Requirement for chimerism to maintain tolerance. Bone Marrow Transplant 9:191, 1992
17. Tomita Y, Sachs DH, Khan A, Sykes M: Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61:469, 1996
18. Tomita Y, Khan A, Sykes M: Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61:477, 1996
19. Sykes M, Szot GL, Swenson KA, Pearson DA: Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 3:783, 1997
20. Lee LA, Sergio JJ, Sykes M: Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation 61:125, 1996
21. Jankowski RA, Ildstad ST: Chimerism and tolerance: From freemartin cattle and neonatal mice to humans (review). Hum Immunol 52:155, 1997
22. Gammie JS, Li S, Colson YL, Demetris AJ, Neipp M, Ildstad ST, Pham SM: A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. Exp Hematol 26:927, 1997
23. Slavin S, Weiss L, Morecki S, Weigensberg M: Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI). Cancer Immunol Immunother 11:155, 1981
24. Slavin S, Strober S, Fuks Z, Kaplan HS: Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 146:34, 1977
25. Leong LY, Qin S, Cobbold SP, Waldmann H: Classical transplantation tolerance in the adult: The interaction between myeloablation and immunosuppression. Eur J Immunol 22:2825, 1992
26. Storb R, Weiden PL, Graham TC, Lerner KG, Nelson N, Thomas ED: Hemopoietic grafts between DLA-identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum. Transplantation 24:349, 1977
27. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ: Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81:2566, 1993
28. Dooren LJ, Vossen JM: Severe combined immunodeficiency: Reconstitution of the immune system following bone marrow transplantation, in van Bekkum DW, Lowenberg B (eds): Bone Marrow Transplantation. Biological Mechanisms and Clinical Practice. New York, NY, Dekker, 1985, p 351
29. Felsburg PJ, Somberg RL, Hartnett BJ, Suter SF, Henthorn PS, Moore PF, Weinberg KI, Ochs HD: Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency, Blood 90:3214, 1997
30. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366, 1968
31. Gatti RA, Good RA: Follow-up of correction of severe dual system immunodeficiency with bone marrow transplantation. J Pediatr 79:475, 1971
32. Woolfrey AE, Nash RA, Frangoul HA, McSweeney PA, Sanders JE, Ochs HD, Storb R: Non-myeloablative transplant regimen used for induction of multi-lineage allogeneic hematopoietic mixed donor-host chimerism in patients with T-cell immunodeficiency. Blood 92:520a, 1998 (abstr, suppl 1)